About DBIS   | Story archive   | Contact DBIS  | DBIS home

Personalized Treatment For Cancer

Biomedical Researchers Personalize Cancer Treatment with 20- Thousand-Sample Database

October 1, 2009

Biomedical researchers are developing a more personalized approach to treating cancer. Because patients with different cancers- from melanoma to colon cancer - receive the same chemotherapies, researchers are attempting to identify the differences between those cancers and the patients, and even between different forms of cancer that can attack an organ like the lungs, for a more focused treatment option. Cancers from more than 20 thousand patients are becoming part of a growing database that includes tissue samples and fluids being examined for possible genetic and molecular signatures of cancer. The resulting evidence-based therapy would create a treatment best for the patient's specific case.

read the full story...

Science Insider

WHAT ARE BLOOD MARKERS? A blood marker is any component in the blood that's associated with a condition, disease or symptom. Doctors look for something in the blood that they know affects, or is affected by, something else. Blood markers can indicate whether a system is healthy and functioning properly or if there's something wrong. In recent years, several studies have shown that greater amounts of proteins in the blood may be associated with various diseases. Identifying such biological markers as early as possible, before the onset of symptoms, could lead to earlier and better diagnoses, and earlier treatment. For instance, if elevated concentrations of certain neural growth "markers" are present at birth, it may be an indication that autism or mental retardation will develop later in childhood.

PERSONALIZED MEDICINE: The Moffitt Cancer Center's effort to collect samples of blood, urine, tumors, and more is intended to build up a database that can be used to draw conclusions about the types of treatments that might work for a particular patient, based upon indicators in their body. Doctors hope to be able to learn more about diseases and treatments, and apply that knowledge on an individual basis. The ultimate goal is to be able to individualize treatments based upon genetic and molecular targets.

Video help

Latest stories

  • A Satellite Named Violet and a Student Named Amanda
  • Behind the Scenes with the K-Team
  • Deep Space Discoveries
  • Dogs Fighting Cancer
  • Earthquake! What's Your Risk

More information on this story

A "Biobank on Steroids"

To Go Inside This Science:
Michelle Foley
Public Information Officer
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL
813-745-1505
michelle.foley@moffitt.org


© 2011 American Institute of Physics